Overview of Paracetamol Teva

Property	Description
Active ingredient	Paracetamol (Acetaminophen)
Form	Tablet / Film-coated tablet
Pharmacological class	Analgesic and Antipyretic
Common use	Symptomatic relief of pain and fever
Origin	Synthetic

What Type of Medicine is Paracetamol Teva?

Paracetamol Teva is defined as a medicinal product whose core active ingredient is paracetamol, globally recognized as acetaminophen. It is classified within the pharmacological class of Analgesics and Antipyretics and is specifically identified as a non-opioid analgesic. This designation confirms its primary function in providing pain relief and reducing fever without being associated with the addictive potential of opioid medications. Paracetamol is recognized as an essential medicine, underscoring its foundational role in basic healthcare. It is used for the management of acute, non-severe pain.

Composition and Origin: Synthetic Single-Component Agent

The medicine is characterized as a single active substance product, containing only paracetamol to exert its therapeutic effect, distinguishing it from combination analgesics. The active molecule is a synthetic compound, produced through controlled chemical synthesis, which ensures a high level of purity and consistency. Paracetamol Teva is a specific generic product designed for oral administration and is typically presented as a solid dosage form, often a film-coated tablet, composed of the active substance and necessary pharmaceutical excipients. Further analysis of the active compound confirms its chemical formula as C8H9NO2.

What is the General Purpose of Paracetamol Teva?

The general purpose of Paracetamol Teva is to offer symptomatic treatment by utilizing its dual analgesic and antipyretic capabilities. As an analgesic, it works to mitigate the discomfort associated with mild to moderate pain stemming from typical causes like headaches or muscle strain. Simultaneously, its antipyretic function helps the body bring down an elevated temperature, providing relief from febrile states. This centralized action allows the product to address two of the most common acute symptoms efficiently by modulating signals within the central nervous system.

Regulatory References

Paracetamol (acetaminophen)

What side effects are possible with Paracetamol Teva?

Possible Side Effects and Safety Information

The official safety documentation for Paracetamol Teva (Paracetamol/Acetaminophen) indicates that adverse reactions occurring at recommended therapeutic doses are predominantly categorized as Very Rare (fewer than 1 in 10,000 patients) or Not Known (frequency cannot be estimated from available data). Most reactions involve the Immune System, Skin and Subcutaneous Tissue, and the Blood and Lymphatic System.

Serious Adverse Reactions

The most critical safety constraint is the potential for acute hepatic failure and hepatic necrosis (severe liver damage), which is a dose-dependent risk primarily associated with acute or chronic overdosage. Liver damage may be delayed, sometimes becoming evident 12 to 48 hours after ingestion. Other serious, though very rare, systemic risks documented include anaphylactic shock and severe cutaneous adverse reactions (SCARs), such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

Safety Constraints and At-Risk Populations

Regulatory documents emphasize that the medicine must not be used concurrently with any other product containing paracetamol. Specific safety considerations are noted for individuals with severe hepatic impairment or severe renal impairment, and those in glutathione-depleted states, such as chronic alcoholism, malnutrition, or sepsis. Patients in these groups may have an increased hazard of liver damage, requiring caution or dose modification. Prolonged or frequent use is generally discouraged as it may be associated with increased risks to the liver and kidneys.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

Overdose Scope

Element	Official Regulatory Description
Documented overdose presentations	Initial manifestations (within the first 24 hours) may include Nausea, Vomiting, and Abdominal pain. Delayed presentations include Jaundice, Hepatic encephalopathy, and Coagulation defects (blood clotting problems).
Physiological systems affected	The primary risk is to the Hepatic system (leading to Acute Liver Failure), the Renal system, and the Metabolic system (e.g., Hypoglycaemia and Metabolic acidosis).
Population-specific overdose notes	Increased risk of severe hepatotoxicity is documented for patients with underlying liver disease or those with conditions causing depleted nutritional reserves.

Emergency Response and Management

Element	Official Regulatory Description
When immediate medical help is required	Immediate medical management is required in the event of suspected overdose, even if symptoms are not present or appear mild.
Antidote information	A specific antidote, Acetylcysteine, exists. Regulatory guidance emphasizes administration within eight hours post-ingestion for maximal protection against severe hepatic injury.
Monitoring and management	Official management protocols require urgent hospital referral for assessment, including measurement of the acetaminophen concentration in the blood and use of the Rumack-Matthew nomogram to guide treatment necessity.

Connection to the Overall Overdose Profile

Regulatory documents define the overdose profile as a time-sensitive medical emergency due to the high risk of delayed-onset Acute Liver Failure, which is listed as potentially fatal and may require a liver transplant. This critical risk mandates that urgent medical attention must be sought in all suspected cases, enabling the timely application of specific supportive measures and the Acetylcysteine antidote.

Therapeutic Uses of Paracetamol Teva

What Paracetamol Teva Treats: Main Uses and Benefits

Paracetamol Teva is commonly used to address symptoms related to physical discomfort and acute pain manifestations that may interfere with daily functioning, such as tension headaches, acute dental pain, or pain associated with menstrual cramps. This medication is classified as an analgesic (pain reliever) and antipyretic (fever reducer). It offers symptomatic relief that may assist with easing the overall symptom load, and contributes to easing discomfort during these difficult episodes.

Key Symptom Domains

The primary indications involve pain and fever, and it is considered relevant across conditions presenting with acute episodes. The medication is commonly used for antipyretic support, assisting with moderating the elevated body temperature characteristic of febrile states. It also provides targeted relief for the pain associated with common musculoskeletal strains, minor post-procedural discomfort, and symptoms of seasonal illnesses.

“The medication may assist with addressing symptom clusters that interfere with daily comfort, contributing to improved functional stability.”

Quick Fact: Relief for Pain and Fever

Paracetamol Teva is applied in addressing situations where short-term symptomatic assistance is needed, such as managing the localized discomfort and fever that may follow routine immunizations or the minor discomfort experienced after small surgical procedures. It provides supportive relief when symptoms interfere with routine activities.

Regulatory References

National Library of Medicine’s MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Paracetamol Teva

Official regulatory documentation defines eligibility for paracetamol-containing products based on age, physiological status, and underlying conditions. The primary exclusion categories are severe contraindications and conditions that require conditional use.

Eligibility Scope

Category	Regulatory Status (Official Documentation)
Populations for whom use is contraindicated	Patients with known hypersensitivity to paracetamol (acetaminophen) or any excipient. Patients with severe hepatic impairment or severe active liver disease [FDA, SmPC].
Populations for whom use is allowed	Adults, adolescents, and children aged 10 years and over are generally eligible for the 500 mg tablet formulation [SmPC].
Populations requiring conditional use	Use with caution in patients with mild to moderate hepatic impairment, severe renal impairment, chronic alcoholism, chronic malnutrition, dehydration, or Gilbert's syndrome [SmPC, FDA]. These conditions may require a reduction in the total daily dose.

Population-Specific Eligibility Status

Population	Regulatory Status
Children under 10 years	The 500 mg tablet formulation is not recommended [SmPC].
Pregnancy	Permitted if clinically needed, but should be used at the lowest effective dose, for the shortest possible time [EMA, MHRA].
Breastfeeding	Permitted in therapeutic doses, with no reported undesirable effects on nursing infants [SmPC, NHS].

The regulatory structure establishes that patients with severe liver disease or known allergies are absolutely contraindicated. All other identified high-risk groups, such as those with chronic alcoholism or low body weight, are subject to restricted or conditional use as defined by the product label.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Paracetamol (Acetaminophen) as described in regulatory labels, focusing strictly on required constraints and effects on co-administered substances.

Official Interaction Statements

Co-administration with any other medicinal product containing paracetamol or acetaminophen is formally prohibited to prevent the risk of severe hepatic injury . This product is also contraindicated in patients with severe hepatic impairment or severe active liver disease.

Metabolic and Absorption Interactions:

Interacting Substance/Class	Official Interaction Outcome
Probenecid (Uricosuric agent)	Reduces paracetamol clearance by inhibiting glucuronidation .
Liver Enzyme Inducers (e.g., Carbamazepine, Rifampicin)	Increase the formation of toxic paracetamol metabolites, raising the risk of hepatotoxicity.
Metoclopramide or Domperidone	Increase the speed and rate of paracetamol absorption.
Cholestyramine (Ion Exchange Resin)	Reduces paracetamol absorption; administration must be separated by at least one hour.

Pharmacodynamic and Substance Interactions:

Prolonged regular daily use may enhance the anticoagulant effect of Warfarin and other Coumarins, requiring monitoring. Concomitant use with Flucloxacillin is associated with an increased risk of High Anion Gap Metabolic Acidosis in at-risk patient populations. The consumption of three or more alcoholic drinks per day is documented to significantly increase the risk of severe liver damage.

Mechanism of Action

Central Targeting of Prostaglandin Synthesis

This mechanism is centered on the inhibition of Cyclooxygenase-2 (COX-2) enzymes predominantly in the Central Nervous System (CNS). By restricting the creation of Prostaglandin E2 ( PGE2) in the brain and spinal cord, the drug engages mechanisms that modulate the excitability of nociceptive neurons and adjust the hypothalamic thermoregulatory set point.

Modulation via Cannabinoid Signaling Pathways

Paracetamol's mechanism includes an indirect pathway involving one of its metabolites, AM404. This substance facilitates the sustained presence of anandamide ( AEA) in the synapse by preventing its reuptake, which results in the modulation of the Cannabinoid Receptor Type 1 ( CB1) signaling pathway.

Specificity and Constrained Physiological Role

The drug's unique mechanism results in a high specificity for central action and a minimal inhibitory effect on COX enzymes at sites of peripheral inflammation. This central specificity results in minimal inhibition of peripheral COX-1 activity, which mediates gastric mucosal and platelet function.

Dosage and Administration Information

Administration and Dosing Guidelines

Paracetamol Teva is a solid oral dosage form (tablet) whose use is based on specific parameters to ensure proper administration. Adherence to these guidelines is important for the intended use of the product.

Standard Adult Use

The medicine is taken orally, typically with a glass of liquid. Its effect may be accelerated if taken without food.

Guideline	Instruction
Single Dose	500 mg to 1000 mg (1 g)
Frequency	Repeat every 4 to 6 hours, as required.
Minimum Interval	4 hours between doses
Max Daily Dose	Not to exceed 4000 mg (4 g) in 24 hours from all paracetamol-containing products.

Population-Specific Dosing

Dose adjustments apply for patients with specific conditions, typically through increasing the time between doses or reducing the total daily limit. For the oral 500 mg form, the dose interval is modified based on the glomerular filtration rate (GFR):

GFR 10-50 mL/min: Dose 500 mg every 6 hours.
GFR <10 mL/min: Dose 500 mg every 8 hours.

In cases of impaired hepatic function (e.g., Gilbert's syndrome or chronic alcoholism), the daily dose is typically reduced, often not exceeding 2 g in 24 hours.

Duration and Restriction

Paracetamol Teva is intended for short-term symptomatic management. In a self-care setting, limitations include not exceeding use beyond 3 days for fever or 5 days for pain without consulting a healthcare professional. It is restricted from use alongside any other product containing paracetamol to avoid exceeding the maximum daily dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Paracetamol Teva

Research Evidence for Acute Pain and Fever Reduction

Studies evaluating Paracetamol Teva's active ingredient are primarily drawn from short-term Randomized Controlled Trials (RCTs) and systematic reviews. These studies monitor outcomes related to physical discomfort (pain intensity) and change in elevated body temperature (fever) over short, defined time intervals in adults and children.

For general mild to moderate pain, studies report measurements observed in the trials shortly after a dose. However, research into continuous management or long-term relief beyond brief episodic use remains limited. For fever, studies reported measurements of change in temperature. Reports indicate that the observed change in temperature was small in some populations, particularly in certain hospitalized adult groups. Research provides limited insight into whether the medicine alters the course of the underlying condition causing the fever.

Evidence for Specific Pain Conditions

Research for osteoarthritis pain utilizes short-term RCTs and long-term observational studies, examining patient-reported outcomes for discomfort and functional measures. Findings are mixed across systematic reviews, with evidence quality remaining low for sustained functional outcomes. For acute low back pain, RCTs reported no measurable difference in patient-reported pain or disability outcomes when compared to a control, indicating that evidence is limited concerning a distinct measurable difference.

Evidence in Special Populations

Research concerning use during pregnancy relies on large-scale observational studies. Regulatory bodies have reviewed these studies, which explored potential associations with certain neurodevelopmental outcomes. Reports indicate that a definitive causal relationship has not been confirmed. Data for children also comes from dedicated pediatric trials that monitored outcomes related to physical discomfort and fever.

What is Still Uncertain About Paracetamol Teva Research

The research base contains limitations, including variability in evidence quality, particularly for long-term or chronic use. For conditions characterized by functional limitations, certainty remains low regarding the consistent clinical significance of measured changes. Data for long-term outcomes following repeated use over months or years remain insufficient.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Paracetamol Teva (FAQ)

Q: How quickly should I expect Paracetamol Teva to start working?

Official information indicates that the onset of pain relief is often noted in approximately 30 minutes after taking the tablet. The medicine typically reaches its peak concentration in the blood within 10 to 60 minutes after oral administration, with the maximum pain-relieving effect usually noted within one to two hours.

Q: What are the signs of an allergic reaction to Paracetamol Teva?

Although allergic or hypersensitivity reactions are rare, official warnings describe symptoms that may include a skin rash, swelling of the mouth, face, lips, or throat, or difficulty breathing or talking. Serious skin reactions are also documented as very rare safety risks. Regulatory documents state that if a serious reaction is suspected, professional medical assistance is required immediately.

Q: Is it possible to become dependent on Paracetamol Teva?

Paracetamol is classified as a non-opioid analgesic, and it is not associated with addiction potential. However, regulatory documents caution that frequent, long-term use (more than three months) may be linked to the development or worsening of medication-overuse headache.

Q: Are there different formulations of Paracetamol Teva (e.g., effervescent, coated)?

The active substance paracetamol is widely available in many different forms, such as tablets, capsules, liquid, and soluble tablets. The specific Paracetamol Teva product described in official documents is typically the film-coated tablet formulation for oral administration, but availability of other forms may vary by market.

Q: Does Paracetamol Teva help with muscle soreness after exercise?

Official therapeutic indications state that the medicine is used for the symptomatic relief of muscle pains and aches. While it is not classified as an anti-inflammatory drug, its pain-relieving action is indicated to help mitigate the discomfort that stems from muscle strain.

Q: How is Paracetamol Teva processed by the body?

After being taken, the medicine is rapidly and completely absorbed from the digestive tract into the bloodstream. It is then extensively broken down, or metabolized, primarily in the liver, and the majority of the drug and its inactive byproducts are subsequently excreted in the urine.

Q: Why do official sources sometimes recommend paracetamol over other pain medicines?

The pharmacological action of paracetamol is concentrated in the central nervous system, resulting in a minimal effect on certain enzymes in the body's periphery. This minimal action helps to preserve the normal function of the stomach lining and platelets. This characteristic supports its use in situations where gastrointestinal tolerability is a consideration.

Q: Does Paracetamol Teva come in different strengths?

The core active ingredient, paracetamol, is available in various strengths across different markets, commonly including 500 mg and 1 g doses. The specific Paracetamol Teva product referenced in core documents is described as the 500 mg tablet formulation.

Q: Is Paracetamol Teva used for period pain?

Yes, official product information includes the symptomatic relief of dysmenorrhoea, commonly known as period pain, as one of the approved uses for the medicine.

Q: What is the average duration of action for Paracetamol Teva?

According to official documents, the duration of the pain-relieving effect is approximately four to five hours. The antipyretic (fever-reducing) effect is often noted to last longer, at approximately eight hours.

Q: Does Paracetamol Teva cause drowsiness or make you tired?

Drowsiness or fatigue is not commonly reported or listed among the known adverse effects of paracetamol when taken alone at the recommended therapeutic doses. If the medicine is taken in combination with caffeine, restlessness or insomnia are possible side effects.

Q: Is it normal to feel a stomach ache after taking Paracetamol Teva?

Adverse effects from paracetamol at therapeutic doses are generally rare. While gastrointestinal irritation is not a primary concern, abdominal pain is often one of the reported symptoms in the event of an overdose.

Q: Are there any known interactions between Paracetamol Teva and caffeine?

Regulatory warnings indicate that excessive intake of caffeine from sources such as coffee, tea, or supplements should be avoided while using paracetamol. High combined doses of caffeine may increase the potential for caffeine-related side effects like restlessness and insomnia.

Q: Does Paracetamol Teva interact with herbal supplements?

Paracetamol is generally not documented to interact with most herbal remedies. However, regulatory bodies generally advise transparency with a healthcare professional regarding all substances being taken, as not all combinations have been formally tested for interactions.

Q: Can Paracetamol Teva be used for toothache relief?

Yes, official therapeutic indications for this medicine explicitly include the relief of discomfort associated with toothache.

Q: What if I forget to take a dose of Paracetamol Teva?

The action to take when a dose is missed relates to maintaining the minimum dosage interval to avoid exceeding the maximum daily limit, as described in the Official Administration Guidelines. If a regular dose is forgotten, the next dose must maintain the minimum required time separation.

Q: Can Paracetamol Teva affect blood pressure?

Official adverse event listings do not commonly include changes in blood pressure at typical doses. However, researchers are continually investigating the relationship between frequent, long-term use of paracetamol and blood pressure in individuals with pre-existing hypertension.

Q: What is the general consensus on Paracetamol Teva's effectiveness for migraines?

The official indication for the medicine includes the relief of headaches. Clinical reviews suggest that a high-dose single dose of paracetamol is statistically superior to placebo for relieving acute migraine symptoms, although it may not be as effective as some specialized prescription treatments.

Q: Can I take Paracetamol Teva while taking an antidepressant?

Official regulatory documents caution that certain types of antidepressants, such as tricyclic antidepressants, may increase the potential for hepatotoxicity (liver damage) associated with paracetamol, especially in cases of overdose. Official labels contain the full interaction profile, which is important for understanding potential risks.

Q: What if Paracetamol Teva doesn't seem to be working for my pain?

Official guidelines state that if pain persists for more than 5 days or fever for more than 3 days, or if symptoms worsen, the clinical situation is described in regulatory documents as needing professional assessment. You must adhere strictly to the maximum daily dose described on the product label.

Q: Does Paracetamol Teva have any effect on sleep?

There is no direct evidence that paracetamol alone, at the prescribed dose, causes significant changes in sleep patterns. However, official information notes that when combined with caffeine, side effects such as insomnia and restlessness are possible.

Q: Can Paracetamol Teva affect the results of any medical tests?

Research indicates that paracetamol and its byproducts may potentially interfere with certain sensitive laboratory methods. Specifically, some specialized tests used to measure certain urinary catecholamines (hormones) and their breakdown products may be affected by the medicine.

Q: What happens if a child accidentally takes Paracetamol Teva?

Official warnings describe overdose as potentially causing serious liver damage and emphasize that the requirement for immediate professional medical assistance is critical, even when the individual appears well. Official regulatory requirements mandate that the medicine be kept out of the sight and reach of children.

Q: Is Paracetamol Teva gluten-free or lactose-free?

Whether the tablets contain gluten or lactose depends entirely on the specific excipients (inactive ingredients) used in the manufacturing process. This specific information is typically detailed in Section 6.1 of the Summary of Product Characteristics (SmPC) document for the product.

Q: What if I have a pre-existing condition, like asthma, and want to use Paracetamol Teva?

While asthma is not listed as an absolute contraindication, some regulatory reviews have noted evidence suggesting an association between paracetamol use and the development or worsening of asthma symptoms, particularly with more frequent long-term use. This remains a topic of ongoing research.

How should Paracetamol Teva be stored and disposed of?

Storage Requirements

Paracetamol Teva tablets are generally stable at controlled room temperature and do not require special storage conditions. The medicine must be kept away from excess heat and moisture and should be stored in the original container, tightly closed, to maintain product stability.

Stability and Child Safety

The product must not be used after the expiry date printed on the packaging. A mandatory regulatory requirement is to keep the medicine out of the sight and reach of children at all times.

Official Disposal Rules

Unused or expired Paracetamol Teva must not be thrown away via wastewater or household waste. Disposal should be handled in accordance with local requirements and pharmaceutical waste protocols, such as using a medicine take-back program or returning the product to a pharmacy.

Paracetamol Teva